
PRT-060318
CAS No. 1194961-19-7
PRT-060318 ( PRT060318 | PRT 060318 | PRT-060318 | PRT318 )
产品货号. M17182 CAS No. 1194961-19-7
PRT-060318 (PRT318) 是一种新型选择性 Syk 酪氨酸激酶抑制剂,可作为 HIT 治疗的一种方法。
纯度: >98% (HPLC)






规格 | 价格/人民币 | 库存 | 数量 |
2MG | ¥389 | 有现货 |
![]() ![]() |
5MG | ¥697 | 有现货 |
![]() ![]() |
10MG | ¥1110 | 有现货 |
![]() ![]() |
25MG | ¥2333 | 有现货 |
![]() ![]() |
50MG | ¥3969 | 有现货 |
![]() ![]() |
100MG | ¥5792 | 有现货 |
![]() ![]() |
200MG | 获取报价 | 有现货 |
![]() ![]() |
500MG | 获取报价 | 有现货 |
![]() ![]() |
1G | 获取报价 | 有现货 |
![]() ![]() |
生物学信息
-
产品名称PRT-060318
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述PRT-060318 (PRT318) 是一种新型选择性 Syk 酪氨酸激酶抑制剂,可作为 HIT 治疗的一种方法。
-
产品描述PRT-060318, also known as PRT318 or P142–76, is a novel selective inhibitor of the tyrosine kinase Syk, as an approach to HIT treatment. PRT318 completely inhibited HIT immune complex-induced aggregation of both human and transgenic HIT mouse platelets. Transgenic HIT model mice were treated with KKO, a mouse monoclonal HIT-like antibody, and heparin. The experimental group received orally dosed PRT318, whereas the control group received vehicle. Nadir platelet counts of PRT318-treated mice were significantly higher than those of control mice. When examined with a novel thrombosis visualization technique, mice treated with PRT318 had significantly reduced thrombosis.
-
体外实验PRT318 is a potent inhibitor of purified Syk kinase with an IC50 of 4 nM. Syk kinase is inhibited by 92%, whereas all other kinases retains more than 70% at a concentration of 50 nM of PRT318. PRT318 and P505-15 effectively antagonize CLL cell survival after B-cell receptor (BCR) triggering and in nurse-like cell-co-cultures. They inhibit BCR-dependent secretion of the chemokines CCL3 and CCL4 by CLL cells, and leukemia cell migration toward the tissue homing chemokines CXCL12, CXCL13, and beneath stromal cells. PRT318 and P505-15 inhibit Syk and extracellular signal-regulated kinase phosphorylation after BCR triggering.
-
体内实验PRT318 completely inhibits HIT immune complex-induced aggregation of both human and transgenic HIT mouse platelets. Pretreatment of mice with PRT318 markedly reduces HIT IC-induced thrombosis in the lungs. The Thrombosis Score is significantly lower for PRT318-treated mice compared with control.
-
同义词PRT060318 | PRT 060318 | PRT-060318 | PRT318
-
通路PI3K/Akt/mTOR signaling
-
靶点mTOR
-
受体Syk
-
研究领域Cancer|Inflammation/Immunology
-
适应症——
化学信息
-
CAS Number1194961-19-7
-
分子量449.81
-
分子式C18H24N6O·3HCl
-
纯度>98% (HPLC)
-
溶解度H2O : 5.6 mg/mL. 16.45 mM;
-
SMILESCC1=CC(=CC=C1)NC2=NC(=NC=C2C(=O)N)N[C@@H]3CCCC[C@@H]3N
-
化学全称2-(((1R,2S)-2-aminocyclohexyl)amino)-4-(m-tolylamino)pyrimidine-5-carboxamide
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years